Keyword: Cervarix


GSK exits U.S. market with its HPV vaccine Cervarix

Facing “very low market demand,” GlaxoSmithKline has decided to pull out of the U.S. market with the HPV vaccine Cervarix. It’s a move that gives Merck a stranglehold on the market as public health officials work feverishly to boost vaccination rates.

CDC aims to boost HPV vax uptake with new two-dose approach

HPV vaccination rates still trail U.S. targets by a sizable margin, but some brand-new CDC guidelines could make a difference. After an advisory committee backed cutting the dose schedule to two shots from three, Director Tom Frieden quickly moved to make the change official.